IBEC group to receive Marató funding for Parkinson’s research
IBEC’s Molecular and Cellular Neurobiotechnology group is to receive funding from 2013’s La Marató de TV3 for their project “Role of the cellular prion protein as “cross-talk” protein between a-syn/ LRRK2 and p-Tau in sporadic and familiar Parkinson´s disease.”
The group’s proposal was one of 44 selected for funding under the annual award, which in its 2013 call focused on neurodegenerative diseases.